We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...

Novo Nordisk (NVO) closed the most recent trading day at $69.30, moving -1.23% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 1.97%.

On Friday, The Centers for Medicare & Medicaid Services (CMS) did not finalize a provision to cover obesity drugs like Eli Lilly's LLY and Novo Nordisk’s NVO popular injections, Zepbound and ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes ... This means that the shortage of these products is resolved and the agency is confident that the company can meet its current and ...

Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest monthly loss since July 2002. Investors are worried that the company is ...